Ivermectin is the active ingredient in several FDA-approved monthly heartworm preventives for dogs and cats. Its approved job is narrow: the canine indication codified at 21 CFR 520.1193(d)(1)(ii) is "to prevent canine heartworm disease by eliminating the tissue stage of heartworm larvae (Dirofilaria immitis) for 1 month (30 days) after infection." That is a larval claim, not an adult-worm claim, and it is why a dog already carrying adult heartworms is not treated by continuing a monthly chewable. For background on ivermectin in dogs generally, including the dose forms that have nothing to do with heartworm, see our companion page.

Two things follow from that narrow indication. First, ivermectin products for dogs and cats are prescription animal drugs: 21 CFR 520.1193(c) states that "Federal law restricts this drug to use by or on the order of a licensed veterinarian" (CFR text retrieved 22 September 2026). Second, the ivermectin pastes, drenches and injections sold for horses, cattle, sheep and swine are labeled for those animals only. They carry no heartworm indication, they are not approved for people, and FDA's consumer update on ivermectin states plainly that animal formulations differ from human ones and their safety in humans is not known.

Key takeaways

  • The approved canine claim covers the tissue stage of D. immitis larvae for 30 days after infection; ivermectin-only products are not effective against adult heartworms (21 CFR 520.1193).
  • The approved canine dose is a minimum of 6.0 mcg/kg (2.72 mcg/lb) monthly in dogs 6 weeks of age and older, delivered through fixed 68, 136 and 272 mcg strengths.
  • Adult infection is treated with an arsenical adulticide given by a veterinarian, not with a preventive. The DIROBAN (melarsomine dihydrochloride) label is restricted to use by or on the order of a licensed veterinarian.
  • The American Heartworm Society states that "slow kill" protocols using preventives instead of an adulticide are not recommended (AHS clinical FAQ, checked 28 September 2026).
  • Livestock and equine ivermectin products are labeled for animal use only, are not approved for people, and several carry an explicit warning that use in other species can be fatal in dogs.

What ivermectin does in heartworm prevention: it kills the larval stage, not adult worms

A monthly dose acts backward, not forward. It clears larvae that entered the dog during the previous 30 days, before those larvae mature. That is the whole of the approved claim in 21 CFR 520.1193(d)(1)(ii), and it is the reason a dose given late leaves a gap that cannot be closed by giving two doses afterward.

Because the claim stops at the tissue stage, ivermectin-only products carry no efficacy statement against adult heartworms living in the pulmonary arteries. If you are comparing macrocyclic lactones with benzimidazoles, pyrantel and the other classes, our page on how it compares with other parasiticides sets the spectra side by side.

The approved products and the label strength for each

The products below are the ivermectin-containing dog and cat products confirmed in FDA's Animal Drugs @ FDA (Green Book) records and DailyMed labels as of 28 September 2026. FDA's Green Book is the place to check for later changes; our approved-product index tracks the wider list, most of which is livestock.

Product Application Ivermectin strength on the label Other actives
HEARTGARD / HEARTGARD 30 Tablets NADA 138-412, originally approved 2 March 1987 68 mcg per tablet or cube None
HEARTGARD Chewables for Dogs NADA 140-886 68, 136 or 272 mcg None
HEARTGARD Plus NADA 140-971 68, 136 or 272 mcg 57, 114 or 227 mg pyrantel (as pamoate salt)
IVERHART PLUS Flavored Chewables (Virbac) ANADA 200-302 68, 136 or 272 mcg Pyrantel pamoate
Tri-Heart Plus Chewable Tablets ANADA 200-338 Ivermectin with pyrantel pamoate Pyrantel pamoate
IVERHART MAX Chew (Virbac) NADA 141-441 34, 68, 136 or 272 mcg Pyrantel pamoate and praziquantel
HEARTGARD for Cats NADA 141-078 55 or 165 mcg None

Two further approved ivermectin products for dogs exist as combinations rather than stand-alone preventives: Panacur Plus chewable tablets for adult dogs (NADA 141-286), whose composition is codified at 21 CFR 520.1200 as 68 mcg ivermectin with 1.134 g fenbendazole and 57 mg praziquantel, or 27 mcg with 454 mg and 23 mg; and Advantage DUO topical solution (NADA 141-208), which under 21 CFR 524.1140 contains 100 mg imidacloprid and 800 mcg ivermectin per mL. For the approved indications of either, read that product's own FDA-approved labeling — several approved ivermectin applications, including HEARTGARD for Cats, Advantage DUO and Panacur Plus, have no current DailyMed label posted as of 28 September 2026.

Age floors differ and are not interchangeable. HEARTGARD Chewables and the ivermectin–pyrantel chewables are labeled for dogs 6 weeks of age and older; the IVERHART MAX Chew label states the product is recommended for dogs 8 weeks of age or older (DailyMed SPL effective 12 February 2024).

Why several add pyrantel or praziquantel, and what that covers

Ivermectin alone covers the heartworm larval stage and nothing else in these dog products. The additional actives widen the spectrum to intestinal worms. The HEARTGARD Plus label on DailyMed (SPL effective 19 October 2023) states the product is for use in dogs to prevent canine heartworm disease by eliminating the tissue stage of heartworm larvae for 30 days after infection "and for the treatment and control of roundworms (Toxocara canis, Toxascaris leonina) and hookworms (Ancylostoma caninum, Uncinaria stenocephala, Ancylostoma braziliense)." Those worm claims come from the pyrantel, not the ivermectin.

Note what the approved indication does not name: whipworms are absent from the roundworm-and-hookworm list quoted above. Praziquantel is the ingredient that distinguishes IVERHART MAX Chew from the two-ingredient chewables; for the exact species each praziquantel-containing product claims, read that product's own label rather than assuming the spectrum transfers between species or dose forms.

The dose as it appears on the approved label, and why the weight bands on the box exist

21 CFR 520.1193(d)(1)(i) states the canine amount as "6.0 mcg per kilogram (kg) of body weight (2.72 mcg per pound (lb)), minimum. Up to 25 lb, 68 mcg; 26 to 50 lb, 136 mcg; 51 to 100 lb, 272 mcg; over 100 lb, a combination of the appropriate tablets," administered at monthly intervals in dogs 6 weeks of age and older.

The bands exist because 6.0 mcg/kg is a minimum, not a target, and because tablets come in fixed strengths. A 26 lb dog and a 50 lb dog both receive 136 mcg; the lighter dog simply gets more per kilogram than the floor requires. Sizing this way guarantees that every dog inside a band clears the minimum, which splitting or estimating from a larger dose form does not.

Cats are dosed on a different scale entirely. Under 21 CFR 520.1193(d)(2)(i), cats up to 5 lb receive 55 mcg and cats from 5 to 15 lb receive 165 mcg, with a recommended minimum of 24 mcg/kg (10.9 mcg/lb) — four times the canine minimum per kilogram. If you keep both species, our page on cats covers the feline products separately.

Prevention is not treatment: what the adulticide protocol is and who administers it

An adult heartworm infection is treated with an arsenical adulticide. The DIROBAN (melarsomine dihydrochloride) label on DailyMed states that federal law restricts the drug to use by or on the order of a licensed veterinarian, that it is indicated for the treatment of stabilized heartworm disease caused by immature to mature adult D. immitis infections, and that it "should be administered by deep intramuscular injection in the epaxial (lumbar) muscles (L3 - L5) ONLY," never intravenously and never into another muscle group.

That is a veterinary procedure with staging, stabilization and strict activity restriction around it, not something a monthly chewable substitutes for. The American Heartworm Society, whose current Canine Heartworm Guidelines update was announced on 9 April 2024, treats melarsomine-based therapy as the recommended approach for infected dogs.

The slow-kill approach and what the American Heartworm Society currently says about it

"Slow kill" means using a heartworm preventive, with or without doxycycline, in place of an adulticide. The AHS clinical FAQ comparing the two (checked 28 September 2026) says such regimens are "not recommended by the AHS," and gives its reasons: slow kill can take a year or much longer, during which disease progresses; it is less effective at eliminating adult worms than melarsomine and the timing of worm death is unpredictable; and it demands strict compliance and exercise restriction throughout.

AHS also notes that alternative protocols have been studied, including work with ivermectin and moxidectin, because not every infected dog is a candidate for melarsomine — in some countries the drug is not approved or not available. That is a description of research and of clinical constraint, not an endorsement of substituting a preventive for treatment.

Why the label requires a negative test before starting

FDA's Green Book record for HEARTGARD Chewables (NADA 140-886) carries the limitation that all dogs should be tested for heartworm infection before starting the product. The reason is structural: since the approved claim stops at the larval stage, an already-infected dog put straight onto a monthly chewable stays infected while its owner reasonably believes it is protected, and the infection goes on damaging the heart and lungs.

AHS advises testing before a dog is started on a preventive and annual testing afterward even for dogs given prevention year-round, because prevention can fail through a missed, late, spat-out or vomited dose.

MDR1 (ABCB1) and the herding breeds: what the gene does and where to get a dog tested

The MDR1 gene, also called ABCB1, encodes P-glycoprotein, a transporter at the blood–brain barrier that limits how much of certain drugs reaches the brain and helps excrete them. Dogs carrying the mutation — historically identified in collies and related herding breeds — can have severe reactions to some drugs that unaffected dogs tolerate.

On heartworm products specifically, Washington State University's Program in Individualized Medicine (PrIMe) states that all heartworm products labeled for dogs in the United States have been tested in dogs with the MDR1 mutation as required by FDA and have been found to be safe. The concern arises at much higher doses used for other purposes, not at monthly preventive doses. Testing is offered by the WSU PrIMe laboratory and by veterinary genetic testing services; your veterinarian can advise which sample type and provider to use, and the result is worth having on file before any drug decision, not after.

What happens if a dose is missed

A missed or late dose leaves a window in which larvae acquired during that period were never cleared. AHS advice for pet owners is to consult your veterinarian, restart the monthly preventive immediately, and have the dog retested later rather than immediately — an infection cannot be detected by testing until the worms have matured. Where there has been a lapse of one or more late or missed doses, AHS advises testing at the time of the lapse and then retesting on the schedule your veterinarian sets.

The label itself is unambiguous about frequency: 21 CFR 520.1193(d)(1)(i) specifies administration at monthly intervals, and nothing in the approved dosing contemplates doubling up to compensate.

Why cattle and equine products are not heartworm preventives

Livestock and equine ivermectin products are labeled for animal use only, are not approved for people, and are not approved for dogs. The differences are not cosmetic. Under 21 CFR 520.1192, ivermectin paste is approved at 1.87 percent and 0.153 percent; the horse dose is 200 micrograms per kilogram (91 micrograms per pound), and the cattle paste dose is 23 milligrams per 250 pounds with a 24-day pre-slaughter withdrawal. One ZIMECTERIN 1.87% syringe (NADA 134-314) holds 6.08 g of paste — enough for one 1,250 lb horse, with each plunger marking delivering a 250 lb dose. None of these products carries a heartworm prevention indication.

Compare the scale: 200 mcg/kg for a horse against a minimum of 6.0 mcg/kg monthly for a dog. There is no way to meter a 68 mcg canine dose from a syringe graduated in 250 lb increments. The regulations also carry species warnings in their own text. The sheep drench limitation at 21 CFR 520.1195(e)(2)(iii) reads: "For use in sheep only. Do not use in other animal species as severe adverse reactions, including fatalities in dogs, may result." 21 CFR 522.1192(d)(2) requires injectable ivermectin labeling to bear the same precaution word for word, and the IVOMEC Injection label (NADA 128-409) repeats it, adding that the product was developed specifically for cattle, swine, reindeer and American bison only. Why the human and animal versions are not interchangeable is covered on our page about animal-only labelling.

Frequently asked questions

Does ivermectin kill heartworms in dogs?

It kills the tissue stage of D. immitis larvae for 30 days after infection, which is the approved claim at 21 CFR 520.1193(d)(1)(ii). Ivermectin-only products are not effective against adult heartworms.

Can I use horse or cattle ivermectin paste to prevent heartworm in my dog?

No. Those products are labeled for animal use only in the species named on the label, carry no heartworm claim, and are dosed on a completely different scale. Several ivermectin livestock labels and the regulations behind them warn that use in other animal species may cause severe adverse reactions, including fatalities in dogs.

Is ivermectin for dogs available without a prescription?

Not lawfully. 21 CFR 520.1193(c) restricts ivermectin tablets and chewables for dogs and cats to use by or on the order of a licensed veterinarian.

Is the ivermectin in HEARTGARD different from the generics?

The active ingredient and strengths match. HEARTGARD Chewables (NADA 140-886) and HEARTGARD Plus (NADA 140-971) are the pioneer approvals; IVERHART PLUS (ANADA 200-302) and Tri-Heart Plus (ANADA 200-338) are approved generic versions in FDA's Green Book. Flavoring, chew matrix and age floors can differ, so read each label.

Do dogs with the MDR1 mutation need to avoid heartworm preventives?

According to Washington State University's PrIMe laboratory, all heartworm products labeled for dogs in the United States have been tested in MDR1-mutant dogs as required by FDA and found safe. Discuss any MDR1 result with your veterinarian before other drugs are prescribed.

Is there an ivermectin heartworm preventive for cats?

Yes — HEARTGARD for Cats (NADA 141-078) is approved in 55 and 165 mcg chewables for cats 6 weeks of age and older, with a recommended minimum of 24 mcg/kg.

Sources